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Abstract
Background: Streptococcus pneumoniae is a leading cause of meningitis in countries where pneumococcal conjugate
vaccines (PCV) targeting commonly occurring serotypes are not routinely used. However, effectiveness of PCV would be
jeopardized by emergence of invasive pneumococcal diseases (IPD) caused by serotypes which are not included in PCV.
Systematic hospital based surveillance in Bangladesh was established and progressively improved to determine the
pathogens causing childhood sepsis and meningitis. This also provided the foundation for determining the spectrum of
serotypes causing IPD. This article reports an unprecedented upsurge of serotype 2, an uncommon pneumococcal serotype,
without any known intervention.
Methods and Findings: Cases with suspected IPD had blood or cerebrospinal fluid (CSF) collected from the beginning of
2001 till 2009. Pneumococcal serotypes were determined by capsular swelling of isolates or PCR of culture-negative CSF
specimens. Multicenter national surveillance, expanded from 2004, identified 45,437 patients with suspected bacteremia
who were blood cultured and 10,618 suspected meningitis cases who had a lumber puncture. Pneumococcus accounted for
230 culture positive cases of meningitis in children ,5 years. Serotype-2 was the leading cause of pneumococcal meningitis,
accounting for 20.4% (45/221; 95% CI 15%–26%) of cases. Ninety eight percent (45/46) of these serotype-2 strains were
isolated from meningitis cases, yielding the highest serotype-specific odds ratio for meningitis (29.6; 95% CI 3.4–256.3). The
serotype-2 strains had three closely related pulsed field gel electrophoresis types.
Conclusions: S. pneumoniae serotype-2 was found to possess an unusually high potential for causing meningitis and was
the leading serotype-specific cause of childhood meningitis in Bangladesh over the past decade. Persisting disease
occurrence or progressive spread would represent a major potential infection threat since serotype-2 is not included in PCVs
currently licensed or under development.
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Introduction
Streptococcus pneumoniae is estimated to cause .60,000 meningitis-
associated deaths plus a poorly defined burden of long-term
disability in children #5 years of age world-wide every year [1].
Meningitis is one of the most severe disease manifestations of a
wide spectrum of invasive pneumococcal disease (IPD). Pneumo-
nia and bacteremia account for the bulk of this invasive disease,
representing an estimated 14.5 million cases and 735,000 deaths in
HIV negative children globally per annum [2]. Pneumococcal
conjugate vaccines (PCVs) offer the hope to prevent this burden of
disease worldwide.
There are currently three PCVs licensed[PCV-7 (Prevnar 7H)
and PCV-13 (Prevnar 13H)], respectively, manufactured by Pfizer
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e32134and conjugated to diphtheria CRM197 protein; and PCV-10
(SynflorixH) a product of GlaxoSmithKline conjugated to Protein
D, a non-typeable Haemophilus influenzae protein, as well as to
tetanus toxoid and diphtheria toxoid proteins). Thus, a limited
number of the .90 known pneumococcal capsular antigens that
determine different serotypes, are currently incorporated in these
vaccines. The capsular polysaccharide antigens included in these
vaccines are based on the predominant serotypes causing IPD in a
variety of settings around the world. This is not ideal for
optimizing prevention of IPD in developing countries, since there
is little cross-serotype protection and in the developing world and a
substantial proportion of IPD is caused by non-vaccine serotypes
[3]. Sudden rises in prevalence of currently rare serotypes would
further undermine the effectiveness of these vaccines.
We preliminarily reported a high prevalence of serotype-2 IPD
in Bangladesh [4], and here we now describe in detail S. pneumoniae
serotype-2 as a leading cause of childhood pneumococcal
meningitis based on 9 years (2001 to 2009) of surveillance.
Methods
Invasive pneumococcal surveillance in Bangladesh
Surveillance of bacteremia and meningitis etiology in children
,5 years based at Dhaka Shishu Hospital (DSH) has been ongoing
since January 2001. DSH is situated in Dhaka City (population 12
million) and is the only tertiary-care pediatric hospital in
Bangladesh (population 150 million, the eighth most populous
country in the world). Based on physician’s judgment, blood
culture was performed on suspected pneumonia and sepsis cases
and lumbar puncture was undertaken on all cases of suspected
meningitis. Through March 2004, data were recorded only for
either blood or CSF cultures growing pneumococci.
Surveillance was extended to partial national pediatric surveil-
lance of IPD on April 2004 by incorporating seven hospitals (DSH
plus six new sites, one rural and five urban) in three districts [4,5].
From 1 January 2009 onwards the surveillance was limited to the
four high performing hospitals reporting the majority of cases.
Pneumococcal isolates and any surplus CSF were sent to the
microbiology laboratory at DSH. The age, gender, date of illness
and residential addresses were collected on all cases. Locations of
the case were collected by hand-held Magellan 350 Geographical
Positioning System (GPS).
Case definition of IPD
Pneumococcal meningitis was defined as isolation of S.
pneumoniae from CSF, or from blood when the concurrent CSF
was culture negative but contained $10 white cells 610
6/L.
Additional cases of pneumococcal meningitis were ascertained by
detection in CSF (with $10 white cells 610
6/L) of pneumococcal
capsular antigens or pneumococcal-specific DNA sequence by
PCR, see below. Cases of non-meningitis IPD consisted of those
patients growing pneumococci from blood culture, who did not
undergo lumbar puncture or on CSF examination had ,10 white
cells 610
6/L.
Microbiological methods, detection of antimicrobial
activity in CSF and non-culture detection of
pneumococci in CSF
Blood and CSF were cultured as described previously [4].
Pneumococcal isolates were identified using standard methods [4],
and preserved in media containing 2% skimmed milk, 3%
tryptone, 10% glycerol and 0.5% glucose (STGG) at 270uC.
Samples with surplus CSF were archived at 270uC. Pneumococ-
cal isolates were serotyped by the conventional capsular swelling
method as previously described [4]. Presence of antimicrobials in
patients with $10 white cells610
6/L was assayed on CSF using a
disc-based agar plate bio-assay as previously described [4].
Pneumococcal antigen testing of surplus CSF was performed on
all culture-negative CSF samples with $10 white cells 610
6/L,
when blood cultures were also negative. The pneumococcal latex
agglutination test (LAT) (Wellcogen Bacterial Antigen Kit; Remel
Europe Ltd, Kent, UK) was initially used, and from 2004
onwards, if negative by LAT, CSF was next tested by
immunochromatographic test (ICT) (Binax NOW Streptococcus
pneumoniae test, Inverness Medical Professional Diagnostics,
Princeton, NJ, USA), both according to the manufacturer’s
instructions.
PCR detection of pneumococcal sequences targeting the
pneumolysin gene (ply-PCR) as previously described [6] was also
performed on surplus CSF only for the specimens collected at
DSH. PCR-based serotyping for the 38 most prevalent serotypes,
using 38 pairs of primers as previously described [7], was
performed on all non-culture pneumococcal positive specimens
containing sufficient residual CSF.
Genotyping of pneumococcal isolates
Isolates were analyzed using pulsed-field gel electrophoresis
(PFGE) according to standard protocols [8,9,10]. Multi-locus
sequence type (MLST) was performed and analyzed using
eBURST as previously described [11,12,13].
Ethics
This study on invasive pneumococcal disease surveillance was
approved by the ethics review committee of the Bangladesh
Institute of Child Health, Dhaka Shishu Hospital, and the
International Centre for Diarrhoeal Disease Research, Bangladesh
(ICDDR,B). Written informed consents were taken from parents
or legal guardian of all participants for this surveillance.
Data management and analysis
Data were entered into Epi-data and analyzed using STATA 9
(StataCorp, US). An empirical odds ratio (OR) for meningitis-
causing potential was calculated for each serotype with $10 IPD
cases relative to all the serotypes with ,10 IPD cases, referred to
here as ‘other serotypes’ (as the reference group), following the
approach for calculating serotype-specific invasive ratios [14].
Serotype-specific ORs were calculated for each serotype causing
culture-positive meningitis and total IPD using the following
equation: OR=(ad)/(bc), where a is the number of meningitis-
causing isolates for a specific serotype, b is the number of total IPD
isolates for the same specific serotype, c is the number of
meningitis-causing ‘other serotype’ isolates, and d is the number
of total IPD ‘other serotype’ isolates. We interpret the odds ratio as
a measure of serotype-specific propensity to cause meningitis.
Role of the funding sources
The sponsors of the study had no role in study design, data
collection, data analysis, data interpretation, or writing of the
report. The corresponding author had full access to all the data in
the study and had final responsibility for the decision to submit for
publication.
Results
Culture-positive IPD cases
S. pneumoniae was isolated from 342 children ,5 years old; 230
were cases of meningitis and 112 were cases of non-meningitis
IPD. Of these isolates, 333 (221 meningitis and 112 non-
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and were excluded (Table 1 and Table S1, Table S2). Of the four
leading serotypes, serotype-2 was the most common serotype
causing meningitis during the observation period (n=45; 20.4%;
95% CI 15%–26%) followed by serotype 12A (n=17; 7.7%, CI
4%–11%), serotype 1 (n=16; 7.2%, CI 4%–11%) and serotype 5
(n=14; 6.3%, CI 3%–10%). For 6 of the 9 years of surveillance,
2003–2008, serotype 2 was the leading serotype causing
meningitis, although only one case was isolated in 2001 and in
2009 no culture positive cases were identified (Figure 1).
Of the 342 pneumococcal cases, 280 were recorded as part of
the partial national pediatric surveillance commencing in 2004 for
which denominator data was available. 45,437 patients were blood
cultured and 10,618 suspected meningitis cases had lumbar
puncture performed. Only 2,490(23%) of these yielded a cell
count $10 white cells 610
6/L. Of these abnormal CSF
specimens, 378(15%) grew a pathogen. Of these, 174 were S.
pneumoniae, which was the leading species-specific cause of
childhood meningitis, accounting for 46% (174/378; 95% CI
42%–50%) of cases that yielded a pathogen. Of the 45,473
potentially septic patients, 42,947 were considered non-meningitis
cases, either on clinical grounds or because the CSF yielded ,10
white cells610
6/L. A pathogen was grown from 3,300 (7.7%) and
of these, 106 (3.2%) were S. pneumoniae.
Themedianageforserotype-2caseswas3 monthscomparedto 7
months for other serotypes (P,0.00001; Wilcoxon rank test,). The
agegroup differencebetween serotype-2(median age4 months)and
other serotypes (median age 5 months) was similar for culture
negative cases of pneumococcal meningitis; (P,0.007; Wilcoxon
rank test) (Figure 2). Compared to other serotypes, the OR for
serotype-2 causing meningitis (n=45 isolates) versus total IPD
(meningitis and bacteremia, n=46 isolates) was 29.6 (95% CI: 3.4–
256.3),p,0.001,thehighestamongallserotypesanalyzed(Table2).
Ascertainment of further cases by non-culture methods
and antimicrobial activity in CSF
Of the 2,112 culture-negative CSF samples from the partial
national pediatric surveillance, 1,181 contained surplus CSF for
further testing. These were processed by the LAT and ICT tests, of
which 386 were positive for pneumococci, 84 were positive for
Haemophilus influenzae type b and 22 for Neisseria meningitidis. Of the
687 samples negative by LAT and ICT tests, 17 were found to be
positive by ply-PCR. Of the 403 LAT, ICT or ply-PCR positive
CSF samples, 217 had sufficient amount for PCR serotyping; 124
were successfully typed, while 93 could not be typed.
Serotype-2, similar to culture positive cases, comprised the
largest sub-set of the culture-negative cases, accounting for
33(27%; 95% CI 19%–34%) cases; 22 (18%, CI 11%–24%) were
serotype-14, 21 were serotype-1 (17%, CI 10%–24%) and 48
consisted of 13 other serogroups/serotypes (Table S3). Fewer
serotype-2 cases were detected in 2009, mirroring the decline
observed in 2009 among culture positive cases (Figure 1).The large
number of pneumococcal meningitis cases detected only by non-
culture methods suggests that many had prior exposure to
antibiotics. Sufficient CSF was available for antimicrobial
substance testing from 639 CSF samples collected as part of the
partial national pediatric hospital surveillance. Antimicrobial
activity was detected in 348 (54%; CI 51%–58%) of these samples;
79%in the culture-negative group (n=160) and 25% of the
culture-positive group (n=87) (Table S4).
Geographic distribution of serotype-2 cases in
Bangladesh
Thegeographicaldistribution ofthe caseswasmappedtoplaceof
residence using GPS technology for cases identified during 2001
through 2009. Of the 78 serotype-2 meningitis cases (45 culture-
positive and 33 detected by non-culture methods), 69 were traced.
These were scattered widely throughout the surveillance area, with
the highest concentration in Dhaka city, the main referral base for
DSH and possessing the highest population density (Figure S1).
Community health workers’ visits to households and interviews with
families of cases did not reveal any clustering within Dhaka city.
Genotypic relatedness by PFGE and MLST
Of the 46 serotype-2 isolates cultured, 41 were available for
genotyping (Figure 3). PFGE identified three types (A, B & C)
differing by only 2 or 3 bands and, therefore, would be regarded as
closely related [9]. By MLST, these 41 isolates belonged to a single
clonal complex, CC74, consisting of 3 sequence types (ST): ST 74
(n=23) the ancestral type, a single locus variant ST 5083 (n=3) and
a double locus variant ST 5199 (n=15). These latter two STs are
unique to this study. This serotype-2 clonal complex is genetically
unrelated to other rare serotype-2 sequence types onthe http://www.
mlst.net database; including the archetypal whole genome sequenced
historic strain D39 designated ST 595(Figure 4 and Table S5).
Discussion
This study shows that S. pneumoniae was the leading species-
specific cause of childhood meningitis during the last decade in
Table 1. IPD Isolates from Children ,5 years between 2001 and 2009.
Isolates fully serotyped Isolates excluded
d
Surveillance Category Meningitis Non-meningitis Total Missing
e Non-typable
f Total Total all isolates
2001–2003
a 51 6 57 3 2 5 62
2004–2008
b 156 92 248 3 1 4 280
2009
C 14 14 28 0 0 0 28
Total 221 112 333 6 3 9 342
a=Surveillance period which included only DSH.
b=Speriod which included DSH and 6 other hospitals.
c=Surveillance period which included DSH and 3 other hospitals.
d=Cases with these isolates were excluded from the analysis.
e=Missing indicates isolate was not retrievable from the isolate archive.
f=Non-typable indicates that the isolates were not among the known serotypes.
doi:10.1371/journal.pone.0032134.t001
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PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e32134Figure 2. Age Distribution of Serotype-2 Pneumococcal Meningitis Cases Compared to All Other Serotypes. This depicts the frequency
by age of the serotype-2 compared to non serotype 2 pneumococcal meningitis cases in children ,5 years. The median and interquartile ranges were
3 months (1 to 4) and 7 months (4 to 9) respectively.
doi:10.1371/journal.pone.0032134.g002
Figure 1. Cases of Pneumococcal Meningitis by Leading Serotypes Detected According to Culture or Non-Culture Methods. This
depicts the percentage of meningitis cases ,5 years by the leading serotypes identified by culture (A) and non-culture (B) detection methods. In
brackets, (N), under the year along the x axis indicates the total number of serotype detected in that year. The number above each serotype-2 solid
black bar in the histogram represents the number of isolates.
doi:10.1371/journal.pone.0032134.g001
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Serotype-2 pneumococcus was the leading serotype-specific cause
during the surveillance period, accounting for 20% of the culture
positive meningitis cases with a very strong predilection for causing
meningitis (OR=29.6) compared with bacteremic IPD. Another
distinctive feature of this pneumococcal serotype was that it
affected younger children compared with all other serotypes and it
also consisted of a genetic lineage of highly related STs.
Routine, comprehensive population-based surveillance is not
established throughout Bangladesh [15], which prevents determi-
nation of the nation-wide incidence of meningitis. Consequently,
the full extent and impact of serotype-2 pneumococcal meningitis
is difficult to ascertain. The study, however, took advantage of
rigorous, ongoing hospital-based surveillance with concomitant
careful laboratory investigation of cases. Serotype-2 was also
sporadically isolated during the period of passive surveillance from
1993 to 2000, when 15 cases were identified (, two cases per year)
[16,17]. Since the end of 2009, four culture-positive serotype-2
cases, all with meningitis, have been recorded (data not shown).
Since we conducted surveillance in several large hospitals and used
sophisticated laboratory methods to identify the serotypes, we are
confident that serotype-2 pneumococcal meningitis over the
observation period was the predominant cause of pneumococcal
childhood meningitis. The recent observation of fewer cases may
be chance variation or alternatively suggestive of epidemic like
behavior typical of serotype-1, which is known to cause epidemics
of IPD and specifically meningitis in West Africa [18,19,20].
The geographic range and burden of serotype-2 IPD in
Bangladesh and surrounding countries is difficult to determine
because active surveillance with serotype testing in regions
surrounding Bangladesh is limited or non-existent. The number
of cases identified in this study is likely to be an underestimate of
the burden, as only a minority of sick children with symptoms of
meningo-encephalitis present to hospitals in Bangladesh [21].
Also, the very substantial exposure to antibiotics (.50% of
meningitis cases) likely reduced the detection of cases. For these
reasons, it is possible that a major burden of serotype-2
pneumococcal meningitis could go unrecognized. Intriguingly, a
small-scale report of 28 invasive pneumococcal disease patients
from Nepal [22] included two cases (ranking 3
rd in serotype
Table 2. Meningitis-causing potential of serotype 2
compared to other serotypes.
Serotypes Meningitis/total IPD (%) Odd Ratio (95% CI
") p-value
2 45/46 (98%) 29.6 (3.4–256.3) ,0.001
1 16/35 (46%) 0.6 (0.3–1.2) 0.1
5 14/25 (56%) 0.8 (0.4–2.0) 0.7
12A 17/20 (85%) 3.7 (1.0–13.7) 0.03
14 11/17 (65%) 1.2 (0.4–3.5) 0.7
45 10/17 (59%) 0.9 (0.3–2.6) 0.9
6B 8/13 (62%) 1.1 (0.3–3.4) 0.9
7F 9/13 (69%) 1.5 (0.4–5.1) 0.5
18C 9/11 (82%) 3.0 (0.6–14.5) 0.2
Other
¥ 82/136 (60%) 1.
1
"CI= confidence interval.
¥40 other serotypes; non-typable (N=3) and missing strains (N=6) were
excluded from this analysis.
1The reference category is: other serotypes (grouped).
doi:10.1371/journal.pone.0032134.t002
Figure 3. Restriction Fragments Generated by Pulsed-Field Gel Electrophoresis. Showing banding patterns of serotype 2 representing 3
different pulsetypes, A (N=36), B (N=4)& C (N=1), detected from Sma1 digested genomic DNA.
doi:10.1371/journal.pone.0032134.g003
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this serotype in a neighboring country. Furthermore, a wider
spectrum of serotypes could contribute to pneumococcal menin-
gitis, as 93 (43%) of the 217 antigen-positive CSF samples failed to
yield a result on serotype-specific PCR that was limited to about a
third of the 90 possible serotypes identified.
In the 1930 s, serotype-2 was a major cause of pneumococcal
pneumonia but apparently not meningitis. In a large series of
991serotype-2 adult pneumonia cases observed in the US , 46% of
which were bacteremic, only 24 cases (2.4%) manifested meningitis
[23,24]. Recent reports on 70 years of pneumococcal serotype
secular trends from the USA and Denmark showed disappearance
in the 1960 s of serotype-2 from reports of IPD [25,26]. In the
1970 s, serotype-2 was still a major cause of pneumonia among
SouthAfricanminers[27],butwasnot overtlydescribedashavinga
propensity for causing meningitis. Serotype-2 IPD is now rare in
South Africa [28,29]. No recent reports of high-incidence serotype-
2 IPD could be found in the published literature.
It is not possible to determine whether Bangladesh is a major
persisting reservoir of serotype-2 pneumococci or whether this
serotype-2 meningitis-causing lineage is emerging as a new variant.
Genetically, the lineage occurring in Bangladesh is distinct from the
historic strain D39 isolated in the early 1900 s.The meningitis-
causing feature of the serotype-2 pneumococcal lineage reported
here is unusual or even unparalleled for a pneumococcus in having
such a high odds for causing meningitis. In studies of meningitis
from Africa, compared to serotype-1, serotype 2 did not account for
a prominent proportion of meningitis cases [18,19,20]. It raises the
question of whether a variant with specific central nervous system
tropism has recently evolved within the clonal complex CC74 in
Bangladesh which differentiates it from the members of the same
lineage observed in West Africa [11]. Typically, such a new
bacterial variant would undergo clonal expansion yielding indistin-
guishable isolates. The PGFE and MLST typing results are broadly
consistent with such a phenomenon. However, the MLST data
indicate there are three closely related STs: ST 74, ST 5083 and ST
5199 (the latter twobeing uniqueto Bangladesh) all belongingto the
same clonal complex CC 74. These data are commensurate with
thesethreemembersofCC74havingcirculated forsufficienttimeto
accumulate such sequence diversity. The three STs occurred
consistently overtheobservation period,suggesting that evolutionof
this diversity antedated the sampling period.A better understanding
of the possible genetic basis for this meningitis-causing trait awaits
further investigation, including whole genomic sequence analysis
and comparative genomics, which is ongoing.
The high proportion of meningitis associated with this serotype-
2 pneumococcus strain highlights the potential for a serotype that
was perceived to have nearly vanished to materialize as a major
cause of IPD and pneumococcal meningitis in particular. Owing
to its rarity in recent reports of IPD, serotype-2 has not been
deemed a likely candidate for inclusion in any currently planned
conjugate vaccine. It is unclear whether serotype-2 represented by
this clonal complex will remain a dominant cause of meningitis in
Bangladesh, spread to neighboring countries or even re-emerge as
a major cause of IPD in regions where it had disappeared.
This study confirms the importance of ongoing surveillance
before and after vaccine introduction, as well as the potential for
substantial shifts in serotype profiles in the absence of vaccine
Figure 4. Depiction of eBURST analysis of the serotype 2 data available on http://www.mlst.net/. This is a depiction of an eBURST
analysis of the serotype 2 data available on http://www.mlst.net/. The founding sequence type (ST) of the only clonal complex is ST 74, marked by the
dark blue node. For the Bangladeshi isolates, the majority (n=23) belonged to ST 74. The two other sequence types 5083 (n=3) and 5199 (n=15)
were single and double locus variants of sequence type 74 respectively. The relative proportions are reflected in the light blue and light pink circles
around the respective nodes. Epidemiological data recorded on http://www.mlst.net indicates CC 74 is the dominant lineage recorded among those
MLST and they originate mainly from West Africa.
doi:10.1371/journal.pone.0032134.g004
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candidates that provide protection across serotypes such as
protein-based vaccine candidates.
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